A
AprilBio Co Ltd
KOSDAQ:397030
AprilBio Co Ltd
KOSDAQ:397030
Price:
59 500
KRW
0.68%
Market Closed
Market Cap:
₩1.4T
Cash Flow Statement
Cash Flow Statement
AprilBio Co Ltd
AprilBio Co Ltd
Currency: KRW
| Mar-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
(50 139)
|
10 430
|
(8 959)
|
(9 267)
|
(14 130)
|
(13 650)
|
4 926
|
1 808
|
20 005
|
22 629
|
959
|
(878)
|
|
| Depreciation & Amortization |
524
|
581
|
593
|
610
|
674
|
701
|
882
|
1 054
|
706
|
696
|
693
|
692
|
|
| Stock-Based Compensation |
541
|
433
|
379
|
380
|
960
|
1 339
|
1 791
|
2 351
|
2 127
|
2 274
|
2 250
|
1 427
|
|
| Other Non-Cash Items |
56 494
|
(1 998)
|
(1 873)
|
(2 373)
|
1 690
|
2 467
|
2 529
|
3 707
|
(812)
|
(988)
|
(747)
|
(376)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2 619
|
890
|
3 535
|
(509)
|
1 707
|
1 727
|
(18 071)
|
2 688
|
2 060
|
300
|
23 648
|
4 036
|
|
| Cash from Operating Activities |
9 498
N/A
|
9 902
+4%
|
(6 704)
N/A
|
(11 539)
-72%
|
(10 059)
+13%
|
(8 755)
+13%
|
(9 734)
-11%
|
9 257
N/A
|
21 960
+137%
|
22 637
+3%
|
24 553
+8%
|
3 474
-86%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(617)
|
(222)
|
(90)
|
(238)
|
(512)
|
(662)
|
(693)
|
(737)
|
(445)
|
(271)
|
(251)
|
(329)
|
|
| Other Items |
(35 619)
|
(33 067)
|
(31 552)
|
(20 016)
|
(6 542)
|
(7 052)
|
(7 051)
|
(27 165)
|
(22 352)
|
(23 531)
|
(21 660)
|
(328)
|
|
| Cash from Investing Activities |
(36 236)
N/A
|
(33 289)
+8%
|
(31 642)
+5%
|
(20 254)
+36%
|
(7 054)
+65%
|
(7 714)
-9%
|
(7 744)
0%
|
(27 902)
-260%
|
(22 797)
+18%
|
(23 802)
-4%
|
(21 911)
+8%
|
(656)
+97%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
21 486
|
20 577
|
20 800
|
1 755
|
1 649
|
1 986
|
2 403
|
1 098
|
1 109
|
939
|
654
|
|
| Net Issuance of Debt |
(176)
|
(234)
|
(248)
|
(256)
|
14 556
|
14 535
|
14 456
|
14 376
|
(3 611)
|
(3 620)
|
(3 630)
|
(3 642)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
24 779
N/A
|
21 252
-14%
|
20 328
-4%
|
20 544
+1%
|
16 312
-21%
|
16 184
-1%
|
16 442
+2%
|
16 779
+2%
|
(2 513)
N/A
|
(2 511)
+0%
|
(2 691)
-7%
|
(2 989)
-11%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
226
|
1 624
|
924
|
826
|
103
|
102
|
182
|
(779)
|
111
|
(10)
|
(273)
|
855
|
|
| Net Change in Cash |
(1 732)
N/A
|
(512)
+70%
|
(17 093)
-3 241%
|
(10 423)
+39%
|
(697)
+93%
|
(183)
+74%
|
(854)
-367%
|
(2 645)
-210%
|
(3 240)
-23%
|
(3 686)
-14%
|
(321)
+91%
|
684
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
8 882
N/A
|
9 680
+9%
|
(6 794)
N/A
|
(11 777)
-73%
|
(10 571)
+10%
|
(9 417)
+11%
|
(10 427)
-11%
|
8 520
N/A
|
21 514
+153%
|
22 366
+4%
|
24 303
+9%
|
3 145
-87%
|
|
Switch to:
Switch to:
See Also
Discover More
